0001846253-23-000099.txt : 20230815
0001846253-23-000099.hdr.sgml : 20230815
20230815165653
ACCESSION NUMBER: 0001846253-23-000099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230814
FILED AS OF DATE: 20230815
DATE AS OF CHANGE: 20230815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOEHR MATTHEW W
CENTRAL INDEX KEY: 0001237556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40720
FILM NUMBER: 231175587
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES RD #200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OmniAb, Inc.
CENTRAL INDEX KEY: 0001846253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 600
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-250-7800
MAIL ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 600
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Avista Public Acquisition Corp. II
DATE OF NAME CHANGE: 20210212
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2023-08-14
0
0001846253
OmniAb, Inc.
OABI
0001237556
FOEHR MATTHEW W
5980 HORTON STREET, STE 600
EMERYVILLE
CA
94608
1
1
0
0
President and CEO
0
Common Stock
2023-08-14
4
P
0
45000
5.48
A
2332919
D
Restricted Stock Units
Common Stock
10770
10770
D
Restricted Stock Units
Common Stock
33173
43943
D
Restricted Stock Units
Common Stock
53107
97050
D
Restricted Stock Units
Common Stock
79665
176715
D
Restricted Stock Units
Common Stock
109375
286090
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.370 to $5.590. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Reporting Person previously reported certain awards of Restricted Stock Units (RSUs) in Table I of Form 4, but has elected to report the RSUs in Table II going forward. As a result, the total reported in Column 5 of Table I has been updated to subtract 286,090 RSUs outstanding on August 14, 2023.
Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in full February 15, 2024.
Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in full December 31, 2023.
Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in two substantially equal annual installments beginning February 15, 2024.
Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in three substantially equal annual installments, beginning December 7, 2023.
Represents RSUs previously reported in Table I. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Vesting shall occur in three substantially equal annual installments, beginning April 7, 2024.
By: /s/ Charles S. Berkman For: Matthew W. Foehr
2023-08-15